Back to DE D. E. Shaw & Co., Inc.

SNDXSNDX
Showing 8 of 26 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in SYNDAX PHARMACEUTICALS INC

D. E. Shaw & Co., Inc. holds 1.2M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $27.1M as of 2026-Q2. The position was decreased (-22.6% shares). SNDX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$27.1M

Current Shares

1.2M

Total Value Change

+$20.3M

Total Shares Change

+887,596

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-22.6%
$27.1M0.0%$21.86
0
2026-Q1
Increased
1.6M
+31.4%
$37.4M0.0%$21.40
37
2025-Q4
Increased
1.2M
+13.2%
$25.6M0.0%$20.74
32
2025-Q3
Increased
1.1M
+67.2%
$16.6M0.0%$15.56
42
2025-Q2
Decreased
644,542
-18.2%
$6M0.0%$9.04
0
2025-Q1
Increased
787,587
+327.8%
$9.7M0.0%$13.18
45
2024-Q4
Decreased
184,117
-47.8%
$2.4M0.0%$12.52
0
2024-Q3
Increased
352,358
+140.3%
$6.8M0.0%$18.89
44

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used